Space

NASA to Study Human Health, Performance During Crew-13 Mission

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 25/09/2026, 10:50:25 UTC.

Briefings

NASA's Crew-13 mission includes a new collaboration with ESA to study venous hemostasis, where astronauts will undergo MRI scans and blood draws to track blood flow changes in microgravity. A separate study tests manual piloting skills using lunar-landing simulations to assess how long-duration spaceflight affects sensory systems and motion control. Crew members will also participate in the B-Complex study to evaluate whether daily B-vitamin supplements can prevent or treat Spaceflight-Associated Neuro-ocular Syndrome (SANS). The Human Research Program aims to establish baseline physiological data and refine re-entry procedures to support future Artemis and Mars missions.

Key points

• A new collaboration with ESA called Venous Haemostasis will study blood flow and clotting during the Crew-13 mission by combining blood collections and physiological data from astronauts.

Context and limitations

Evidence covers Crew-13 preflight training at SpaceX headquarters in Hawthorne, California, dated April 30, 2026. Research findings remain preliminary as the article is a preprint and does not include results from past studies or future Artemis missions.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 25/09/2026, 10:51:50 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeidtkdep4apgnllubgzrhnqcynij2crldjzt5n7oqdyywji6c3auqu